QUBIC director brings the future to 300 Brisbane students

Centre Director Professor Warwick Bowen took to the stage at the annual Churchie Physics Lecture to explore how quantum technologies are poised to transform medicine — and why that future is closer than most people think.

On 12 May, around 300 high school students from across Brisbane gathered at Anglican Church Grammar School (Churchie) for the school’s annual Physics Lecture. This year’s keynote was delivered by QUBIC’s Director, Professor Warwick Bowen, whose talk — How quantum is set to change medicine — traced the journey from the fundamental strangeness of quantum mechanics to its growing role in medical imaging, drug discovery, and brain science.

Warwick opened by grounding students in Quantum 1.0: the first revolution in quantum understanding that already underpins technologies many take for granted — from MRI and PET scans to magnetoencephalography. He then turned to Quantum 2.0, the era we’re now entering, in which scientists are actively engineering quantum phenomena to do things classical technology simply cannot.

“These students are going to inherit a world shaped by quantum technology — and most of them don’t know it yet. If even a few of them walk away wanting to understand the physics behind an MRI machine, or curious about what a quantum computer could mean for drug development, then the evening did exactly what it should.”

— Professor Warwick Bowen, Director, QUBIC

The lecture drew on QUBIC’s three grand challenges: imaging and modelling individual protein molecules in real time, understanding how cell-scale behaviour emerges from molecular interactions, and achieving whole-brain electromagnetic imaging at single-neuron resolution. Warwick illustrated each with concrete examples — from the exponential complexity that makes molecules so hard to simulate, to quantum diamond microscopes and the prospect of next-generation brain scanners affordable enough to reach regional hospitals.

The evening was a strong success. Warwick noted enthusiastic engagement throughout, with students asking questions that reflected genuine curiosity about both the science and its real-world stakes. Elizabeth Jenkins, Head of Physics at Churchie, echoed that sentiment in a note to the Centre afterwards, describing the evening as something students “value enormously” and extending an open invitation for QUBIC to return.

Outreach events like this one are central to QUBIC’s mission — bringing the science of quantum biotechnology out of the lab and into the broader community, and helping the next generation of students see themselves as part of that story.

Queensland’s Quantum Decarbonisation Alliance appoints its leadership team 

Meeting net-zero commitments will require faster, deeper innovation across energy, materials and industrial systems — and many of the hardest decarbonisation problems now sit beyond the limits of today’s tools. The Queensland Quantum Decarbonisation Alliance was established to change that, bringing quantum capability to the places where conventional approaches fall short. 

As the Alliance accelerates from establishment to delivery, the $30 million initiative has appointed its inaugural leadership team. 

Prof. Eleanor G. Rieffel joins as Director, and Kayla Warner as Manager — formalising the leadership of a 27-partner consortium built to apply quantum technologies to one of the defining challenges of our time. 

Handing over the keys 

The QDA was established through QUBIC, alongside core partners the University of Queensland, Griffith University, PsiQuantum, and CSIRO — part of a broader 27-partner consortium. The partners span quantum science, decarbonisation research and carbonintensive industry including Siemens, Aurizon and Energy Queensland, creating a structure that connects frontier capability with realworld need. 

Prof. Warwick Bowen, Director of QUBIC, has spent the past 18 months working with partners to establish the Alliance, secure funding and build the consortium, before handing over to the incoming leadership team. QUBIC remains a core research partner in the Alliance’s work. 

“Some of the most persistent decarbonisation challenges now sit beyond the limits of classical computing and sensing. Quantum technologies open new opportunities, and Australia is well placed to translate this capability into real world impact. The QDA was set up to do just that at scale and Eleanor and Kayla bring the right combination of technical depth, leadership and partnership experience to take the Alliance from foundation to delivery.”
— Prof. Warwick Bowen, Director, QUBIC
  

Prof. Eleanor G. Rieffel — Director 

Prof. Rieffel arrives from NASA’s Ames Research Center, where she led the Quantum Artificial Intelligence Laboratory (QuAIL) and served as NASA Senior Researcher for Advanced Computing and Data Analytics. One of the world’s leading experts in making quantum computers practically useful, her research spans quantum algorithms, quantum error correction, logical and fault-tolerant architectures, and resource estimation for future real-world applications of quantum technologies. She is the co-author, with Wolfgang Polak, of Quantum Computing: A Gentle Introduction (MIT Press, 2011) — one of the most widely read introductions to the field. 

“The vision propelling my work is to see quantum computers enhance the world by solving high-impact computational problems of societal value. As director of the Queensland Quantum Decarbonisation Alliance, I look forward to inspiring others, both students just starting their careers and established researchers in other fields who are curious about quantum computing, to contribute to this fascinating field. I’m excited to build on the already strong foundation of quantum science in Queensland to deepen the research around and the practical impact of this emerging technology.”
— Prof. Eleanor Rieffel, Director, Queensland Quantum Decarbonisation Alliance
 

Kayla Warner — Manager 

Kayla joins from UQ’s Global Partnerships team, where she built international partnerships across North America, Latin America, and the Pacific.  She brings deep experience working at the intersection of research, industry, and government across the energy transition, critical minerals, health, education, and advanced technology sectors. 

“Joining an alliance at this stage — when the strategy, partnerships and operating model are still being built — is a rare opportunity. There’s a lot of work ahead, but the foundations are exceptional. The ambition is significant, and the foundations are strong. I’m here to help translate that ambition into highimpact partnerships and outcomes that genuinely accelerate decarbonisation.”
— Kayla Warner, Manager, Queensland Quantum Decarbonisation Alliance 

Already on the ground 

Prof. Eleanor G. Rieffel and Kayla Warner hit the ground running with the QDA’s first upskilling event on Thursday 7 May at Customs House, Brisbane — bringing together industry, government, and research professionals for a half-day of practical tutorials on quantum sensing and quantum computing, delivered by experts from QUBIC, Griffith University, and PsiQuantum. 

More information about the QDA, its research program, and its 27 partner organisations is available here. 

Queensland’s Quantum and Life Sciences Communities Come Together to Explore Drug Discovery Collaborations

On Friday 1 May, QUBIC hosted a roundtable bringing together researchers, industry partners, and government representatives to explore how quantum computing could accelerate drug discovery and life sciences research in Queensland and beyond.

The event, held at the Global Change Institute Building at The University of Queensland, was convened in partnership with QuEra Computing Inc. — a global leader in neutral-atom quantum computing with a growing portfolio of pharmaceutical and biomedical research collaborations. Attendees represented a cross-section of Queensland’s quantum ecosystem, including researchers from the University of Queensland and Griffith University, representatives from Queensland Government’s Department of the Environment, Tourism, Science and Innovation (DETSI), and industry partners including Sanofi and IBM.

The session was designed to surface shared research interests and identify concrete pathways for collaboration at the intersection of quantum computing and life sciences — from molecular simulation and reaction dynamics to drug discovery pipelines and antimicrobial resistance.

QUBIC Director Professor Warwick Bowen reflected on the quality of the discussion: “It was a pleasure to host the roundtable between QuEra and the Queensland quantum algorithms, molecular simulations and pharma communities. I think we established a strong base on which to build meaningful collaborations.”

Tommaso Macri, Senior Director of Business Development at QuEra Computing Inc., noted the depth of the technical exchange: “What stood out was how concrete the conversation became. The group quickly moved toward specific scientific problems in molecular simulation, reaction dynamics, and drug discovery. They discussed where current methods fall short and explored where QuEra’s capabilities in neutral-atom quantum simulation, error-corrected systems, and application co-design could add value. That is the kind of grounded dialogue we need to identify collaborations worth pursuing.”

For Helen Burns of IBM, the energy in the room was equally striking: “The highlight was seeing the desire from industry, the state sector, and the academic community to close the gap between what was unknown in science and what could be explored through quantum computing — and the desire to keep talking and learning about deep pockets of scientific expertise and the possibilities quantum computing offers.”

The roundtable marks the beginning of an ongoing collaborative process to work towards identifying high-impact problems in pharmaceutical research where quantum computing can deliver a meaningful advantage — and to map the partnerships and funding mechanisms needed to pursue them.

Reshaping How Scientists Explore the Physical Behaviour of Living Systems

Optical trapping and manipulation, which is the use of precisely shaped laser beams to hold, rotate, and measure microscopic structures, is reshaping how scientists explore the physical behaviour of living systems. These light‑driven tools allow researchers to quantify forces, observe rapid motions, and detect subtle mechanical changes inside cells at extremely small scales. Many of these measurements were previously out of reach, yet they are crucial for understanding how cells function, adapt and respond to stress or disease triggers. 

At The University of Queensland, the Rubinsztein‑Dunlop lab is at the forefront of this work. Dr Mark Watson is one of the researchers expanding what optical tweezers can do, having recently completed his PhD, Mark is continuing to advance the methods. His specialty lies in rotational and ballistic optical tweezers, which are platforms that can track the rotation of microscopic probes at exceptionally high speeds. These techniques allow scientists to capture dynamic processes in cell‑like environments on millisecond timescales, revealing biological activity that happens too quickly for many conventional tools to detect.

A major focus of Mark’s research is improving how we measure the physical properties of tiny biological environments. Using rotational optical tweezers he has developed targeted approaches to measure the fluid properties within cells by using light to control and twist a microscopic spherical probe. These measurements reveal physical signatures that provide clues about how cells move, change shape and perform their functions. Mark’s published studies show these tools in action in living cells and soft biological materials, highlighting their potential to uncover early signs of changes linked to health or disease.

Mechanical properties inside cells, such as viscosity, stiffness and force transmission, are central to processes including cell division, development, immune responses and disease progression. Tools that can measure these properties directly and in real time give scientists a window into how life operates at the smallest scales. Mark’s work enables exactly this – fast, sensitive and minimally disruptive measurements that can capture the physical “early warning signs” of how a cell is changing. These capabilities are essential for studying disease mechanisms, testing drugs and uncovering how subtle physical shifts influence biological behaviour.

As QUBIC develops quantum‑enhanced sensing and imaging technologies, high‑precision optical trapping systems will form a vital bridge between classical photonics and emerging quantum tools. Mark’s improvements to stability, bandwidth and calibration help ensure these platforms are ready for integration with quantum light sources and quantum‑enabled readouts, future techniques that promise to reveal biological processes with unprecedented sensitivity.

Continuing as a postdoctoral researcher in the Rubinsztein‑Dunlop lab, Mark is now extending his work into new regimes where optical manipulation is combined with faster detection, new forms of structured light and emerging approaches from quantum photonics. The application of his research is guided by close collaboration with cell biologists across QUBIC to determine which biological problems to tackle and what further developments are needed. These developments will contribute directly to QUBIC’s mission to create the next generation of precision tools for understanding life at its most fundamental scales.

Scientia Professor Michelle Simmons AC appointed Companion of the Order of Australia

QUBIC congratulates Scientia Professor Michelle Simmons AC, Advisory Board member, on her appointment as a Companion of the Order of Australia (AC) – the nation’s highest civilian honour.

Professor Simmons received the award “for eminent service to quantum physics and nanotechnology research, to atomic-scale engineering, to technology innovation and commercialisation, and to STEM education.”

An internationally recognised leader in atomic‑scale electronics, Professor Simmons has pioneered techniques that allow devices to be engineered with atom‑by‑atom precision in silicon. Her team has achieved a series of world‑firsts: the smallest transistor, the narrowest conducting wires, 3D atomic electronics, and the first two‑qubit gate using atom‑based qubits in silicon. These breakthroughs underpin emerging silicon‑based quantum computers and have positioned Australia as a global trailblazer in quantum technology.

As Director of the ARC Centre of Excellence for Quantum Computation and Communication Technology and Founder & CEO of Silicon Quantum Computing, Professor Simmons has combined fundamental research excellence with a strong commitment to commercialisation and national capability building.

“Professor Simmons’ recognition as a Companion of the Order of Australia is a testament to her vision and leadership in shaping Australia’s quantum future. We are fortunate to have her insight on the QUBIC Advisory Board, where her deep expertise helps guide our mission to translate quantum technologies into real impact for biotechnology, health, and society.”
– Professor Warwick Bowen, Director, QUBIC

Professor Simmons’ appointment as AC highlights not only her scientific leadership, but also her role in shaping a strong, forward‑looking quantum ecosystem in Australia.

QUBIC is honoured to have her expertise and strategic vision informing our mission to advance quantum biotechnology for societal benefit.

Quantum meets neuroscience in the fight against MND

In a lab in Wollongong, researchers are combining neuroscience and quantum physics to tackle one of medicine’s most devastating conditions: motor neurone disease (MND) – a group of progressive neurological disorders that affects the nerve cells controlling voluntary muscle movement, leading to weakness, paralysis, and respiratory failure.

Dr Dzung Do-Ha, based in the Ooi lab, is leading the research that uses quantum diamond sensing to peer into the workings of patient-derived neuronal cultures – a kind of ‘disease-in-a-dish’ model sometimes nicknamed ‘tiny brains in a dish” – to better understand motor neurone disease (MND). A neuroscientist by training, she’s now working at the cutting edge of quantum biotechnology.

Dzung’s background is in biology and neuroscience, but her current work sits at the intersection of life sciences and quantum technologies. Through QUBIC, she’s collaborating closely with Dr Dan McCloskey at the University of Melbourne, bringing together expertise in quantum sensing and neurobiology. This kind of cross-disciplinary research is central to QUBIC’s mission: to apply quantum tools to real-world biological problems.

Diamond voltage imaging microscopy (DVIM) is a technique that uses nitrogen-vacancy (NV) centres in lab grown diamonds to detect magnetic fields and voltage changes at extremely small scales. These sensors can pick up the faint electrical signals generated by neural activity in neuronal cultures, offering a non-invasive way to study how neurons behave and interact. This is especially valuable in MND research, where understanding early changes in neural function could lead to better diagnostics and treatments.

Using patient-derived iPSC neurons – mini ‘avatars’ of each person’s nervous system – provide a powerful model for studying disease in a controlled environment. By combining them with quantum sensors, Dzung’s team can observe neural dynamics with a level of detail that traditional methods can’t. This approach could help detect early changes in neural activity before symptoms appear, identify biomarkers for diagnosis and monitoring, and provide a platform for testing potential therapies, all without needing to access human brain tissue.

This research is unfolding during the International Year of Quantum Science and Technology 2025, a global initiative highlighting the growing impact of quantum technologies. Dzung’s work shows how quantum sensing is moving beyond physics labs and into applications that could transform healthcare. It’s a solid example of how quantum tools can help answer biological questions that were previously out of reach.

With QUBIC’s support and the collaboration between the Ooi and Simpson labs, Dzung’s research is part of a broader movement to bring quantum technologies into the life sciences. QUBIC hosted the first International Conference on Quantum Technologies in the Life Sciences in November in Wollongong, showcasing how interdisciplinary science can drive innovation.

Dr Dzung Do-Ha is helping to build a future where quantum tools are part of everyday biomedical research. Her work on MND is not only advancing our understanding of the disease but also showing what’s possible when neuroscience and quantum physics come together to solve real-world problems.

In 2025, Dzung was recognised as an emerging leader in quantum biotechnology, being awarded the QUBIC Rising Star Award for advancing QUBIC’s vision by bridging quantum sensing with neurodegenerative research.

QUBIC Chief Investigator Dr Elizabeth Hinde Recognised for Research Leadership and Excellence

QUBIC is proud to celebrate two significant achievements by Chief Investigator Dr Elizabeth Hinde from the University of Melbourne – recognition that highlights her leadership in biophysics and her role in shaping Australia’s research future.

International Recognition in Biophysics
Elizabeth has been honoured by the Biophysical Society with the Michael and Kate Bárány Award for her exceptional contributions to understanding genome function through advanced imaging. Her research explores how the architecture of the cell nucleus influences gene expression, replication, and repair. By combining fluorescence microscopy, spectroscopy, and live-cell imaging, Liz reveals how chromatin, the 3D structure that packages our DNA, rearranges in real time.

Her pioneering imaging methods not only advance biophysics but also lay the foundation for quantum-enhanced bioimaging, an area central to QUBIC’s mission to transform life sciences with quantum technologies.

Appointment to ARC College of Experts
Elizabeth has also been appointed to the Australian Research Council’s College of Experts, a prestigious role that plays a critical part in identifying research excellence and shaping national priorities to advance knowledge and drive innovation.

Her appointment ensures that interdisciplinary research, including quantum-enabled biotechnology, has a strong voice in Australia’s research future. It reflects Liz’s standing as an expert of international reputation and reinforces QUBIC’s leadership in bridging physics, biology, and quantum technologies.

Liz’s achievements demonstrate the power of interdisciplinary science and its role in shaping the future of health and life sciences. Congratulations, Liz, on these outstanding achievements!

Celebrating Excellence: QUBIC’s Inaugural Annual Awards

Congratulations to everyone who was nominated and to the winners of QUBIC’s inaugural awards! At the QUBIC Annual Symposium, we were proud to honour the incredible people and teams whose work has shaped our Centre in 2025.

These awards recognise excellence across research, collaboration, engagement, and leadership because QUBIC’s success is built on the passion and commitment of its people. From groundbreaking science to inspiring outreach, these achievements reflect the spirit of innovation and collaboration that drives our mission to bring quantum to life.

Our 2025 Award Winners

🌟 Scientific Achievement – Brain Theme
Dr Dzung Do-Ha and Dr Dan McCloskey
For establishing and using a diamond voltage imaging microscope (DVIM) system, to image the electrical activity of neurons as well as characterise subcellular structures relevant to neurodegenerative diseases including MND. Their collaborative work has enabled the first single-shot, label free images of neuronal activity – a major step forward for QUBIC’s Brain Theme.

🌟 Scientific Achievement – Molecule Theme
Dr Martin Stroet
For developing and maintaining the Automated Topology Builder (ATB), a global resource used by thousands of researchers and paving the way for quantum approaches in molecular modeling and drug discovery.

🌟 Scientific Achievement – Cell Theme
Dr Nicolas Mauranyapin
For developing a quantum-limited microscope that images living cell activity, opening new possibilities for drug development, cancer diagnostics, and antibiotic resistance testing.

🌟 Ambassador Award
Dr Pavlina Naydenova
For raising QUBIC’s profile through exceptional leadership in outreach and engagement—connecting quantum biotechnology with schools, industry, and government, and inspiring the next generation of quantum thinkers.

🌟 Rising Star Award
Dr Dzung Do-Ha
For advancing QUBIC’s vision by bridging quantum sensing with neurodegenerative research

🌟 Superstars of Outreach Award
Hunter Johnson, Shikun Ma and Dhilan Vallury
For their contribution to the 2025 National Quantum & Dark Matter Road Trip sideshow, designing new activities and delivering 20 demonstrations to over 500 students with exceptional enthusiasm and commitment to promoting science.

🌟 Advancing Equity Award
Dr Mahya Mohammadi
For advancing equity in science through mentoring under-represented students, international representation, and outreach, applying skills from the Elevating Quantum Women’s Voices program to strengthen QUBIC’s culture of inclusion.

🌟 Outstanding Collaborative Paper
Qiang Zhu, Zahra Raza, Dzung Do-Ha, Emma De Costa, Pavlina Sasheva, Luke McAlary, Hadi Mahmodi, Warwick P. Bowen, Lezanne Ooi, Irina Kabakova, Haibo Yu
For publishing a collaborative paper in Advanced Materials that unites three QUBIC nodes and all research themes: Biomolecular Condensates as Emerging Biomaterials: Functional Mechanisms and Advances in Computational and Experimental Approaches.

🌟 Outstanding Team Project
The Mentoring, Training & Development Portfolio Team
For delivering exceptional initiatives in 2025 including QUBIC’s flagship programs – Winter School, UG Summer Internship, and mentoring opportunities that strengthened QUBIC’s culture and amplified its impact.

🌟 Cross-Nodal Collaboration Award
Emma De Costa
For exceptional leadership in fostering cross-theme collaboration, driving multi-node initiatives and building strong connections across teams for their work in TDP-43

🌟 Research Translation Pioneer Award
Prof Alexander Solnstev and the CTCP Project Team
For advancing QUBIC’s work in next-generation quantum spectroscopy diagnostic platforms for heart disease

🌟 Mentor Award
Prof Allison Fish
For creating a truly participatory, inclusive and supportive environment for QUBIC members, where individuals feel heard and valued.

🌟 Director’s Award
Prof Lezanne Ooi
For exceptional leadership as QUBIC’s Brain Theme Lead, driving collaboration and innovation across nodes, integrating quantum science with biomedical applications, and strengthening QUBIC’s culture through mentorship and inclusion.

Why these awards matter
The QUBIC Awards celebrate more than achievements, they recognise the people who make our mission possible. Every winner and nominee has contributed to advancing quantum biotechnology, building collaborations, and shaping conversations that will define the future of science and technology.

Thank you to everyone who contributed to QUBIC’s success in 2025. We can’t wait to see what we achieve together in the year ahead!

Top image: QUBIC’s Mentoring, Training & Development Portfolio Team accepting the award for Outstanding Team Project

Launching the 2025 Connect Initiative: Building Bridges Across Quantum and Life Sciences

In a Centre as ambitious and interdisciplinary as QUBIC, collaboration isn’t just encouraged, it’s essential. The Connect Initiative is our flagship program designed to support researchers in building meaningful, hands-on collaborations across disciplines, institutions, and borders.

It’s about more than travel or internships. It’s about creating the conditions for researchers in quantum science and the life sciences to work together in ways that are thoughtful, productive, and sometimes unexpected.


Why Connect Matters

Quantum biotechnology is a frontier field. It brings together expertise from quantum physics, bioscience, and beyond – and that kind of interdisciplinarity takes time, trust, and shared experience. The Connect Initiative helps make that possible by supporting researchers to:

  • Spend time in unfamiliar lab environments
  • Learn new scientific approaches and techniques
  • Build collaborations that wouldn’t happen through remote meetings alone

What Connect Made Possible in 2024

Earlier this year, three researchers shared how Connect helped them pursue projects that expanded their research and built new connections across the Centre:

  • Dr Marita Rodriguez (UQ) visited labs in Wollongong and Melbourne to explore how authorship and credit are negotiated in interdisciplinary teams. Her work offers practical insights into how recognition is shared and how we can support fairer collaboration, especially for early-career researchers.
  • Dr Sergey Kruk (UTS) travelled to UQ and UoM to bring nanophotonics into biological sensing and quantum measurement. His collaborations showed how photonics can enhance the tools we use in bioscience and quantum sensing, making measurements more sensitive and precise.
  • Dr Benjamin Carey (UQ) worked with researchers at UOW to build a chip-scale platform for measuring muscle-cell contraction. His project bridges quantum optics and live-cell biology, opening new possibilities for studying neuromuscular function at the single-cell level.

These projects reflect the kind of work Connect is designed to support – collaborative, cross-disciplinary, and deeply relevant to QUBIC’s mission.


What’s Available in 2025

The 2025 Connect Initiative is now open to Centre members. This year’s program includes:

  • Internships with industry and government
  • Travel support for international collaboration
  • Exchange placements embedding quantum researchers in bioscience labs, and vice versa

Each stream is designed to broaden your perspective, deepen your expertise, and strengthen the Centre’s interdisciplinary culture.

QUBIC welcomes Professor Muhammad Usman as a new Associate Investigator

Professor Muhammad Usman, a leading expert in quantum computing at CSIRO, has joined QUBIC as an Associate Investigator. His appointment strengthens QUBIC’s mission to translate quantum science into real-world impact, particularly in health and sustainability.

At QUBIC, Professor Usman will contribute to the Queensland Quantum Decarbonisation Alliance (QDA), and collaborate across the Molecule Theme with Prof Alan Mark, Prof Haibo Yu and others, as well as the Brain Theme with Prof Warwick Bowen, Prof Lloyd Hollenberg, Prof Lezanne Ooi and others. His work focuses on developing quantum algorithms that can accelerate breakthroughs in medical imaging, early-stage diagnostics, and drug discovery, bridging the gap between academic research and industry applications.

“Quantum computing is one of the most exciting frontiers in science,” says Professor Usman. “It holds the promise to solve problems that are currently beyond the reach of classical computing, from curing diseases like cancer to discovering new materials for clean energy.”

Professor Usman’s team will work closely with QUBIC researchers to drive innovation, support talent development, and position Australia as a global leader in quantum-enabled health and biotechnology.

When he’s not designing quantum algorithms, Professor Usman enjoys experimenting in the kitchen. “As a theorist, I don’t have a physics lab, so I satisfy my experimental curiosity through cooking,” he says.